QHSLab Inc (USAQ)
QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session
QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dark Blue Therapeutics acquired by Amgen for up to $840 million
Illumina, Inc. - Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
Varex to Participate in CJS Securities 26th Annual New Ideas for the New Year Conference
Day One Completes Acquisition of Mersana Therapeutics
2026 New Year’s Greetings from the CEO
Levi & Korsinsky Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - PRGO
Investors in Integer Holdings Corporation Should Contact Levi & Korsinsky Before February 9, 2026 to Discuss Your Rights - ITGR